Chetankumar Gangadhar Shetty
About Chetankumar Gangadhar Shetty
Chetankumar Gangadhar Shetty has 13 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Nucleotide Healthcare Private Limited and Shetty Enterprises Ventures Llp. Formerly with 1 company, such as Experinn Solutions Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Nucleotide Healthcare Private Limited
U86905KA2025PTC207997
|
Director | 08 Sep 2025 | 2025 | Active |
Shetty Enterprises Ventures Llp
ACA-7729
|
Designated Partner | 19 Jun 2024 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Experinn Solutions Private Limited
U72200KA2012PTC066383
|
Director | 19 Oct 2012 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chetankumar Gangadhar Shetty
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chetankumar Gangadhar Shetty
Chetankumar Gangadhar Shetty has 13 years in corporate governance. Holds Director and Designated Partner roles. Currently with 2 companies, including Nucleotide Healthcare Private Limited and Shetty Enterprises Ventures Llp. Formerly with 1 company, such as Experinn Solutions Private Limited. Engaged in Healthcare, General Business. Contributes to corporate operations.
Chetankumar Gangadhar Shetty is associated with 2 companies as Director and Designated Partner.
Chetankumar Gangadhar Shetty has expertise in Healthcare, General Business.
Chetankumar Gangadhar Shetty has 13 years in corporate governance.